Help me, Doctor! My D-dimer is raised.

Area of Science:

• Biochemistry
• Hematology
• Clinical Diagnostics

Background:

• Diagnostic algorithms for venous thromboembolism (VTE) often include clinical assessment and D-dimer testing.
• D-dimer is a validated biomarker for VTE diagnosis and initial anticoagulant therapy guidance.
• A paradigm shift suggests an expanded role for D-dimer measurement in clinical practice.

Purpose of the Study:

• To highlight the emerging prognostic role of D-dimer beyond VTE diagnosis.
• To emphasize the need for further research into D-dimer's pathophysiological involvement and predictive capabilities.
• To underscore the importance of educating healthcare professionals on D-dimer interpretation and management.

Main Methods:

• Review of existing clinical trials and emerging evidence on D-dimer utility.
• Analysis of D-dimer's prognostic indications in conditions such as VTE, disseminated intravascular coagulation, cardiovascular disease, infections, and cancer.
• Discussion of the need for further studies on D-dimer's active role in pathophysiology and its potential in patient triage.

Main Results:

• D-dimer is a useful biomarker for diagnosing thrombosis and guiding initial anticoagulant therapy.
• Raised D-dimer levels show prognostic value across diverse conditions, including cardiovascular disease and cancer.
• The precise pathophysiological role of elevated D-dimer requires further investigation.

Conclusions:

• D-dimer testing has an established diagnostic role and an emerging prognostic significance.
• Further research is essential to elucidate D-dimer's active role in disease and its utility in patient stratification and treatment.
• Enhanced education on D-dimer hazards and management strategies is critical for medical professionals.